Published in Blood on May 01, 1993
A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia. Blood (2008) 1.07
Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis. Am J Pathol (2004) 1.00
Routine diagnosis of large granular lymphocytic leukaemia by Southern blot and polymerase chain reaction analysis of clonal T cell receptor gene rearrangement. Mol Pathol (1997) 0.88
Pure red cell aplasia and lymphoproliferative disorders: an infrequent association. ScientificWorldJournal (2012) 0.88
The human androgen receptor X-chromosome inactivation assay for clonality diagnostics of natural killer cell proliferations. J Mol Diagn (2007) 0.87
Dermatomyositis associated with lymphoproliferative disorder of NK cells and occult small cell lung carcinoma. Clin Rheumatol (2004) 0.80
Clonality of CD3 negative large granular lymphocyte proliferations determined by PCR based X-inactivation studies. J Clin Pathol (1994) 0.79
Tipifarnib-mediated suppression of T-bet-dependent signaling pathways. Cancer Immunol Immunother (2011) 0.75
Longstanding proliferation of CD3 negative large granular lymphocytes preceding the development of high grade non-Hodgkin's lymphoma. J Clin Pathol (1995) 0.75
Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest (2001) 3.79
ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis (1999) 3.69
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood (1999) 2.97
CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia. Blood (1994) 2.33
Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol (1997) 1.92
Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Ann Intern Med (1985) 1.83
The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood (1997) 1.75
Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol (2001) 1.63
Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes. J Biol Chem (1986) 1.62
The quality of medical evidence in hematology-oncology. Am J Med (1999) 1.57
Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J Immunol (1998) 1.56
Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood (1998) 1.52
Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis. Dig Dis Sci (1989) 1.47
Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur J Immunol (2001) 1.46
The pathology of large granular lymphocyte leukemia. Hum Pathol (1989) 1.44
Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology (2000) 1.42
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med (1994) 1.41
Large granular lymphocyte leukemia. Report of 38 cases and review of the literature. Medicine (Baltimore) (1987) 1.37
Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils. J Immunol (2001) 1.32
Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis. Phenotypic and functional evaluations. Ann N Y Acad Sci (1986) 1.30
High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS (1994) 1.29
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol (1996) 1.29
Redistribution of T lymphocytes in the lymph nodes of patients with sarcoidosis. N Engl J Med (1982) 1.28
CXC chemokines IP-10 and mig expression and direct migration of pulmonary CD8+/CXCR3+ T cells in the lungs of patients with HIV infection and T-cell alveolitis. Am J Respir Crit Care Med (2000) 1.27
State of the art in natural killer cell malignancies. Int J Lab Hematol (2011) 1.26
CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Mod Pathol (1999) 1.23
Immunohistochemical analysis of sarcoid granulomas. Evaluation of Ki67+ and interleukin-1+ cells. Am J Pathol (1988) 1.23
Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol (1996) 1.21
Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun (2000) 1.21
Chronic neutropenia mediated by fas ligand. Blood (2000) 1.20
Bronchoalveolar lavage and lung histology. Comparative analysis of inflammatory and immunocompetent cells in patients with sarcoidosis and hypersensitivity pneumonitis. Am Rev Respir Dis (1985) 1.18
The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Eur J Immunol (1998) 1.17
Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways. Leukemia (2012) 1.16
New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol (2000) 1.16
Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study. Cancer (1990) 1.15
Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J Immunol (1999) 1.15
The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer (1987) 1.15
Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood (1997) 1.14
Current concepts: large granular lymphocyte leukemia. Blood Rev (1999) 1.13
T-cell intestinal lymphoma associated with celiac sprue. Ann Intern Med (1986) 1.13
T cell and NK cell lymphoproliferative disorders. Hematology Am Soc Hematol Educ Program (2001) 1.12
The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. J Clin Invest (1999) 1.09
"The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med (1995) 1.08
CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1. Blood (1995) 1.05
Evidence of cells bearing interleukin-2 receptor at sites of disease activity in sarcoid patients. Clin Exp Immunol (1984) 1.03
Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am J Respir Crit Care Med (1996) 1.03
Mini-allografts: ongoing trials in humans. Bone Marrow Transplant (2000) 1.02
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis (2001) 1.02
HIV-1 and the lung. Infectivity, pathogenic mechanisms, and cellular immune responses taking place in the lower respiratory tract. Am Rev Respir Dis (1993) 1.02
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party. Ann Oncol (2011) 1.02
First report of the Italian register for diffuse infiltrative lung disorders (RIPID). Monaldi Arch Chest Dis (2001) 1.01
Serum reactivity to human T-cell leukaemia/lymphoma virus type I proteins in patients with large granular lymphocytic leukaemia. Lancet (1987) 1.01
Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease. Br J Cancer (1984) 1.00
Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system. Bone Marrow Transplant (1998) 1.00
T-lymphocyte subpopulations in chronic lymphocytic leukemia: a quantitative and functional study. Cancer (1981) 0.99
Vitiligo and polyglandular autoimmune disease with autoantibodies to melanin-producing cells. A new syndrome? Arch Dermatol (1981) 0.99
Adult-onset cyclic neutropenia is a benign neoplasm associated with clonal proliferation of large granular lymphocytes. J Exp Med (1986) 0.99
Phenotypical and functional analysis of bronchoalveolar lavage lymphocytes in patients with HIV infection. Am Rev Respir Dis (1988) 0.99
Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders. Blood (1996) 0.97
Pulmonary alveolar macrophages in patients with sarcoidosis and hypersensitivity pneumonitis: characterization by monoclonal antibodies. J Clin Immunol (1987) 0.97
High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia. Blood (1987) 0.97
Distribution and heterogeneity of cells detected by HNK-1 monoclonal antibody in blood and tissues in normal, reactive and neoplastic conditions. Clin Exp Immunol (1984) 0.97
Immunohistologic study of bone marrow involvement in B-chronic lymphocytic leukemia. Blood (1983) 0.96
Phorbol ester induces abnormal chronic lymphocytic leukemia cells to express features of hairy cell leukemia. Blood (1985) 0.96
The soluble interleukin-2 receptor in haematological disorders. Br J Haematol (1987) 0.96
Immunohistological study in sarcoidosis: evaluation at different sites of disease activity. Clin Immunol Immunopathol (1984) 0.96
Rituximab-responsive CIDP. Eur J Neurol (2004) 0.96
Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process. Am J Physiol (1999) 0.95
Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia (2011) 0.94
B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. Cancer Res (1997) 0.94
Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor. Br J Cancer (1995) 0.94
Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukaemia. Int J Biol Markers (1988) 0.94
Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues. Am J Pathol (1993) 0.93
Immunoregulation in sarcoidosis. Clin Immunol Immunopathol (1981) 0.93